Opening https://www.businesswire.com/news/home/20230324005081/en/Enrollment-Begins-in-FORESEE-Clinical-Trial-Using-Biocept%E2%80%99s-CNSide%E2%84%A2-to-Evaluate-Patients-with-Leptomeningeal-Metastases